The impact of hepatic encephalopathy on liver transplantation outcome
肝性脑病对肝移植结局的影响
基本信息
- 批准号:281674
- 负责人:
- 金额:$ 39.35万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2013
- 资助国家:加拿大
- 起止时间:2013-03-01 至 2018-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Minimal hepatic encephalopathy (MHE) is a serious complication of liver disease characterized by cognitive, psychiatric and motor disturbances that can lead to coma and death. As much as 80% of patients with cirrhosis suffer from MHE, of which the burden
轻微肝性脑病(MHE)是一种严重的肝病并发症,其特征是认知、精神和运动障碍,可导致昏迷和死亡。多达80%的肝硬化患者患有MHE,其中负担
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rose Christopher其他文献
Rose Christopher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rose Christopher', 18)}}的其他基金
Defining the impact of different pathogenic factors on the irreversibility of hepatic encephalopathy in chronic liver disease.
明确不同致病因素对慢性肝病肝性脑病不可逆性的影响。
- 批准号:
490229 - 财政年份:2023
- 资助金额:
$ 39.35万 - 项目类别:
Operating Grants
Obesity exacerbates ammonia-induced neurological dysfunction in cirrhosis
肥胖会加剧肝硬化中氨引起的神经功能障碍
- 批准号:
390212 - 财政年份:2018
- 资助金额:
$ 39.35万 - 项目类别:
Operating Grants
相似海外基金
Defining the impact of different pathogenic factors on the irreversibility of hepatic encephalopathy in chronic liver disease.
明确不同致病因素对慢性肝病肝性脑病不可逆性的影响。
- 批准号:
490229 - 财政年份:2023
- 资助金额:
$ 39.35万 - 项目类别:
Operating Grants
Exploring a novel therapeutic target for hepatic encephalopathy by the comprehensive analysis of the gut microbiome
综合分析肠道微生物群探索肝性脑病的新治疗靶点
- 批准号:
20K08339 - 财政年份:2020
- 资助金额:
$ 39.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy
隐性肝性脑病临床试验的优化措施
- 批准号:
10132309 - 财政年份:2019
- 资助金额:
$ 39.35万 - 项目类别:
Optimizing Measures for Clinical Trials in Covert Hepatic Encephalopathy
隐性肝性脑病临床试验的优化措施
- 批准号:
10382474 - 财政年份:2019
- 资助金额:
$ 39.35万 - 项目类别:
Evaluating a novel, portable, self-administered device ("Flicker-App") that measures critical flicker frequency as a test for minimal hepatic encephalopathy in cirrhosis
评估一种新型便携式自我管理设备(“Flicker-App”),该设备可测量临界闪烁频率,作为肝硬化患者轻微肝性脑病的测试
- 批准号:
9987155 - 财政年份:2019
- 资助金额:
$ 39.35万 - 项目类别:
Elucidation of the molecular mechanism of hepatic encephalopathy and development of innovative treatment by intestinal bacterial flora profiling
通过肠道菌群分析阐明肝性脑病的分子机制并开发创新治疗方法
- 批准号:
18K08684 - 财政年份:2018
- 资助金额:
$ 39.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of repetitive magnetic stimulation on synaptic plasticity deficits in hepatic encephalopathy - cellular and molecular mechanisms (B11#)
重复磁刺激对肝性脑病突触可塑性缺陷的影响 - 细胞和分子机制(B11)
- 批准号:
336086942 - 财政年份:2017
- 资助金额:
$ 39.35万 - 项目类别:
Collaborative Research Centres
Role of mitochondrial quality control in hepatic encephalopathy (B09)
线粒体质量控制在肝性脑病中的作用 (B09)
- 批准号:
290206242 - 财政年份:2016
- 资助金额:
$ 39.35万 - 项目类别:
Collaborative Research Centres
Clinical study of pathogenic mechanism of minimal hepatic encephalopathy using ultra-high magnetic field 7 Tesla MRI
超高磁场7特斯拉MRI探讨轻微肝性脑病发病机制的临床研究
- 批准号:
15K19346 - 财政年份:2015
- 资助金额:
$ 39.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Experimental and clinical studies on the effects of L-carnitine in minimal hepatic encephalopathy
左旋肉碱治疗轻微肝性脑病的实验与临床研究
- 批准号:
25461009 - 财政年份:2013
- 资助金额:
$ 39.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)